Document is current
Any future updates will be listed below
-
Authors
Mesfin, Berihu
Ishioka, Yui
Ichinose, Yoshiki
Inamura, Akihito
Wu, Yingying
Watanuki, Shoichi
Hiraoka, Kotaro
Funaki, Yoshihito
Kikuchi, Asuka
Takeda, Kazuko
Miyake, Masayasu
Harada, Ryuichi
Furumoto, Shozo
Okamura, Nobuyuki
Yanai, Kazuhiko
Watabe, Hiroshi
Tashiro, Manabu https://orcid.org/0000-0002-8860-6917
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (21H02862)
Japan Society for the Promotion of Science (16H06278)
Clinical Research Grant from Tohoku University Hospital (Clinical Research Grant from Tohoku University Hospital)
- License Information
-
More Information
Article History
Received: 22 August 2025
Accepted: 9 December 2025
First Online: 7 January 2026
Declarations
:
: Ryuichi Harada, Shozo Furumoto, and Nobuyuki Okamura have patents pending for the [ 18 F]SMBT-1 molecule described in this article. Nobuyuki Okamura owns stock in Clino Ltd. The authors declare no other potential conflicts of interest relevant to this article.
